Skip to main content

Advertisement

SpringerLink
Log in

Clinical and neuropathological correlates of Lewy body disease

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

We investigated distribution of neuronal and glial inclusions in 30 brains obtained at autopsy from patients with Lewy bodies (LBs) disease, which was clinically diagnosed as Parkinson's disease (PD), dementia with Lewy bodies (DLB), or pure autonomic failure (PAF). The cases were classified, according to the guidelines for the pathological diagnosis of DLB, into three types: the neocortical type, the limbic type, and the brain stem-predominant type. All postmortem brains had coil-like glial inclusions as well as LBs, and the distribution pattern and density of glial inclusions and LBs varied. The distribution of glial inclusions was strikingly similar to that of LBs. In the cerebral cortex in particular, the number of glial inclusions was fairly well correlated with the number of LBs, irrespective of the three pathological types. In the brain stem, distribution was similar between glial inclusions and LBs, and there was no distinct pathological difference among the three types. Glial inclusions and LBs were immunohistopathologically similar with respect to ubiquitin, α-synuclein, and Gallyas-Braak staining. The clinical features of the three types of LB disease were also similar; i.e., parkinsonism, some dementia, and/or autonomic failure. The inclusions in neurons and glial cells occurred in parallel with respect to tissue distribution and immunohistochemical features, suggesting that accumulation of neuronal and glial inclusions in the LB diseases have a common pathological feature. Our findings suggest that DLB, PD with and without dementia, and PAF share one clinicopathological entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239–252

    CAS  PubMed  Google Scholar 

  2. Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein. Neurosci Lett 259:83–86

    CAS  PubMed  Google Scholar 

  3. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93–100

    PubMed  Google Scholar 

  4. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879–884

    CAS  PubMed  Google Scholar 

  5. Braak E, Braak H (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259

    CAS  PubMed  Google Scholar 

  6. De Vos RA, Jansen EN, Atam FC, Ravid R, Swaab DF (1995) 'Lewy body disease': clinico-pathological correlations in18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22

    Article  PubMed  Google Scholar 

  7. Dickson DW, Ruan D, Crystal H Mark MH, Davies P, Kress Y, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLDB) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA 2–3 neurites specific to DLBD. Neurology 41:1402–1409

    CAS  PubMed  Google Scholar 

  8. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26:507–514

    CAS  PubMed  Google Scholar 

  9. Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27:373–385

    CAS  PubMed  Google Scholar 

  10. Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78:194–201

    CAS  PubMed  Google Scholar 

  11. Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, Mabuchi C, Yoshida M, Sobue G (2000) Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Autonom Res 10:139–143

    CAS  Google Scholar 

  12. Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol Appl Neurobiol 27:362–372

    PubMed  Google Scholar 

  13. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    CAS  PubMed  Google Scholar 

  14. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyaman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334–337

    CAS  PubMed  Google Scholar 

  15. Iseki E, Li F, Odawara T, Kosaka K (1997) Hippocampal pathology in diffuse Lewy body disease using ubiquitin-immunohistochemistry. J Neurol Sci 149:165–169

    Article  CAS  PubMed  Google Scholar 

  16. Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K (1999) Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 19:386–394

    Article  Google Scholar 

  17. Jellinger K (1986) Overview of morphological changes in Parkinson's disease. Adv Neurol 45:1–18

    Google Scholar 

  18. Kosaka K (1995) Diffuse Lewy body disease. Clin Neurol 35:1455–1456

    CAS  Google Scholar 

  19. Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathology 16:32–35

    Google Scholar 

  20. Kosaka K, Matsushima M, Oyanagi S, Mehraein P (1980) A clinicopathological study of the "Lewy body disease". Psychiatr Neurol Jpn 82:292–311

    CAS  Google Scholar 

  21. Mann DMA, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 9:3–19

    CAS  PubMed  Google Scholar 

  22. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

    CAS  PubMed  Google Scholar 

  23. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L, participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part Ⅱ. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486

    CAS  PubMed  Google Scholar 

  24. Morris CM, Candy JM, Bloxham CA, Edwardson JA (1992) Immunocytochemical localization of transferrin in the human brain. Acta Anat (Basel) 143:14–18

    Google Scholar 

  25. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37:3200–317

    Google Scholar 

  26. Pearson J, Goldstein M, Markey K, Brandeis L (1983) Human brain stem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3–32

    CAS  PubMed  Google Scholar 

  27. Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. Clin Neuropathol 19:163–169

    CAS  PubMed  Google Scholar 

  28. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Hasegawa M, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840

    CAS  PubMed  Google Scholar 

  29. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473

    Article  CAS  PubMed  Google Scholar 

  30. Terada S, Ishizu H, Haraguchi T, Takehisa S, Tanabe Y, Kawai K, Kuroda S (2000) tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 100:464-468

    CAS  PubMed  Google Scholar 

  31. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM-Y (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44:415–422

    CAS  PubMed  Google Scholar 

  32. Wakabayashi K, Takahashi H (1996) Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain. Neurosci Lett 217:133–136

    Article  CAS  PubMed  Google Scholar 

  33. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14–20

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466–8550, Nagoya, Japan

    Nozomi Hishikawa & Gen Sobue

  2. Institute for Medical Science of Aging, Aichi Medical University, Nagakute-cho, 480–1195, Aichi-gun, Japan

    Yoshio Hashizume & Mari Yoshida

Authors
  1. Nozomi Hishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshio Hashizume
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mari Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gen Sobue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gen Sobue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hishikawa, N., Hashizume, Y., Yoshida, M. et al. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105, 341–350 (2003). https://doi.org/10.1007/s00401-002-0651-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-002-0651-4

Keywords

Search

Navigation